Los Angeles Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,034
Closed -$488K 1424
2022
Q2
$488K Sell
16,034
-35,497
-69% -$1.08M ﹤0.01% 972
2022
Q1
$1.34M Sell
51,531
-6,740
-12% -$175K 0.01% 658
2021
Q4
$1.19M Sell
58,271
-39,790
-41% -$812K ﹤0.01% 667
2021
Q3
$1.89M Sell
98,061
-4,939
-5% -$95K 0.01% 542
2021
Q2
$2.29M Buy
103,000
+51,026
+98% +$1.13M 0.01% 558
2021
Q1
$1.36M Buy
51,974
+7,759
+18% +$204K 0.01% 760
2020
Q4
$826K Sell
44,215
-2,840
-6% -$53.1K ﹤0.01% 1017
2020
Q3
$799K Sell
47,055
-47,141
-50% -$800K ﹤0.01% 907
2020
Q2
$2.19M Buy
94,196
+20,077
+27% +$468K 0.01% 595
2020
Q1
$623K Buy
+74,119
New +$623K ﹤0.01% 839
2019
Q2
Sell
-87,715
Closed -$1.55M 1460
2019
Q1
$1.55M Sell
87,715
-104,990
-54% -$1.85M 0.01% 728
2018
Q4
$3.35M Buy
192,705
+72,036
+60% +$1.25M 0.02% 436
2018
Q3
$1.8M Buy
120,669
+36,952
+44% +$551K 0.01% 695
2018
Q2
$1.33M Hold
83,717
0.01% 814
2018
Q1
$1.19M Sell
83,717
-50,995
-38% -$724K 0.01% 778
2017
Q4
$1.89M Buy
134,712
+47,311
+54% +$662K 0.01% 683
2017
Q3
$1.25M Buy
87,401
+31,140
+55% +$445K 0.01% 748
2017
Q2
$886K Sell
56,261
-6,440
-10% -$101K 0.01% 788
2017
Q1
$865K Buy
62,701
+8,831
+16% +$122K 0.01% 760
2016
Q4
$953K Hold
53,870
0.01% 716
2016
Q3
$1.04M Buy
53,870
+6,810
+14% +$131K 0.01% 709
2016
Q2
$918K Buy
+47,060
New +$918K 0.01% 727